USPTO serial 79386244
GUUD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 30, 2024
- Examiner
- RENNEKER, CHRISTOPHER JOHN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GUUD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vivian Ortiz-Ponce
Vivian Ortiz-Ponce PEREZ GUERRERO LLCP.O. Box 9024163San Juan, PR 00902-4163United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for use in the treatment of metabolic syndrome, obesity and overweight preparations for medical and veterinary use for use in the treatment of metabolic syndrome, obesity and overweight; hygienic and sanitary products for medical use treatment of metabolic syndrome, obesity and overweight; dietetic food and substances for medical or veterinary use for use in the treatment of metabolic syndrome, obesity and overweight; food supplements for persons or animals; capsules for medicines, sold empty for pharmaceuticals; medicines for constipation, dragées, for use in the treatment of metabolic syndrome, obesity and overweight; non-steroidal anti-inflammatory medicines for use in the treatment of metabolic syndrome, obesity and overweight; anti-fungal medicines; anti-malarial medicines; anti-pyretic medicines; Medicated soap for perspiration; anti-tumor medicines; antitussive medicines; cytostatic medicines for medical use; allergy medicines; diarrhea medicines; non-prescription medicines for use in the treatment of metabolic syndrome, obesity and overweight; medicines for adjusting the menstrual cycle; medicine for alleviating allergies; medicines for alleviating pain; acne medicines; medicines for alleviating burns; medicines for the treatment of gastrointestinal diseases; medicines for the prevention of puerperal fever; cough medicines; medicines for medical use for use in the treatment of metabolic syndrome, obesity and overweight; medicines for dental use for use in the treatment of metabolic syndrome, obesity and overweight; medicines for veterinary use for use in the treatment of metabolic syndrome, obesity and overweight serotherapeutic medicines; transdermal patch with medicine featuring preparations for the treatment of metabolic syndrome, obesity and overweight; patches containing medicines featuring preparations for the treatment of metabolic syndrome, obesity and overweight; preparations for use as medicated additives for food for human consumption for use in the treatment of metabolic syndrome, obesity and overweight; sulfonamides medicines; tonics, namely, medicinal drinks; medicines for alleviating constipation; diagnostic agents for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; milk ferments for pharmaceutical use; hormone preparations for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; sunburn products for pharmaceutical use for treating sunburn; capsules for pharmaceutical use, sold empty for pharmaceuticals; tablets for pharmaceutical use, sold empty for pharmaceuticals; cytostatics for pharmaceutical use; amino acid preparations for pharmaceutical use; analgesics for pharmaceutical use; bacteriological preparations for pharmaceutical use; body creams for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; body gels for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight | ACTIVE | — |
| 009 | Downloadable mobile device applications for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; Downloadable software applications for mobile telephones for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; downloadable applications for use with mobile devices for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; Downloadable software and applications for mobile devices for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; downloadable mobile applications for use with portable computer devices for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; downloadable mobile applications for information management; Downloadable computer application software for mobile phones for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; downloadable software being a medical device for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; Downloadable computer programs relating to the medical field for telemedicine, purchasing pharmaceutical products and creating medical and lifestyle content; scales | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical, dental or veterinary use; orthopedic supports; applicators for medicines, namely, dosage dispensers for administering medicine to patients; containers for applying medicines, namely, dosage dispensers for administering medicine to patients; pill crushers; apparatus for analyzing alcohol in body fluids for medical use; apparatus for analyzing alcohol in breath fluids for medical use; measuring devices for medical use for measuring wounds; measuring instruments adapted for medical use for measuring and displaying blood pressure, blood glucose, pulse and breathing frequency; digital thermometers for medical use; electronic analyzers for medical use for analyzing and identifying bacteria; tools for medical diagnosis for analyzing and identifying bacteria; medical diagnostic instruments for analyzing and identifying bacteria; physical exercise apparatus for medical use, namely, portable devices used for endogenous breathing exercises and for respiratory muscle training; physical training apparatus for medical use; weights for physical exercise for physical therapy; electronic blood pressure monitors; testing instruments for medical diagnostic use for measuring and displaying blood pressure, blood glucose, pulse and breathing frequency; apparatus for blood monitoring for medical use; physiological monitoring apparatus for medical use for measuring and displaying blood pressure, blood glucose, pulse and breathing frequency; carbon dioxide indicators for medical use; physical analyzers for medical use for measuring and displaying blood pressure, blood glucose, pulse and breathing frequency; physiological measuring apparatus for medical use for measuring and displaying blood pressure, blood glucose, pulse and breathing frequency; electronic blood oxygen saturation monitors for medical use; analysis apparatus for medical use for measuring and displaying blood pressure, blood glucose, pulse and breathing frequency; apparatus for use in exercising muscles for medical use for physical therapy; medical apparatus for measuring oxygen content in blood; blood glucose meter monitors; body fat meters; blood pressure meters monitors | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care services for human beings or animals; advisory services regarding medicines; providing information concerning the preparation and dispensing of medicines; consultancy relating to health; information and advice services in the field of health; drug use screening services for treatment and diagnosis purposes; laboratory analysis services relating to the treatment of animals; medical analysis services provided by laboratories for the treatment of people; medical laboratory services for the analysis of blood samples taken from patients; medical laboratory services for the analysis of samples taken from patients; medical laboratory services for the analysis of blood samples; laboratory examinations for medical purposes; clinical analysis laboratory services for the treatment of persons; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; telemedicine services; provision of medical assistance; individual medical counseling services provided to patients; medical advice for losing weight; providing medical support in the monitoring of patients receiving medical treatment; medical information; medical consultations; medical care; medical clinics; dietetic and nutritional advice; health advice and health consultancy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FERNANDO GARCIA SADA
- Other trademarks owned by FERNANDO GARCIA SADA
- Other trademarks owned by FERNANDO GARCIA SADA
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named GUUD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 19, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 19, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 13, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 27, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 27, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 15, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 24, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 24, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 31, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 14, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 14, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 24, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 9, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 9, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 9, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 9, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 19, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 19, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 19, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 14, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 25, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 25, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 10, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 9, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 2, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 29, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 28, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |